L-dopa and the Shy-Drager syndrome.
D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005242:Fecal Incontinence / Q000188:drug therapy* / Q000503:physiopathology; D005438:Fludrocortisone / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy* / Q000503:physiopathology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008680:Metaraminol / Q000494:pharmacology; D008875:Middle Aged; D009422:Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology; D010656:Phenylephrine / Q000494:pharmacology; D013577:Syndrome; D014549:Urinary Incontinence / Q000188:drug therapy* / Q000503:physiopathology
D010656:Phenylephrine; D008680:Metaraminol; D007545:Isoproterenol; D005438:Fludrocortisone